World✓ Authenticity 87% · 1 Sources
US FDA Approves AstraZeneca Imfinzi Regimen for Muscle-Invasive Bladder Cancer
The regulatory approval covers a perioperative treatment pathway combining Imfinzi with enfortumab vedotin followed by post-surgical monotherapy.
By Zainab Qureshi (Islamabad)Sat, 14 Nov 2026 · 20:55 PKT